Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised SmartCella Holding AB in connection with fund raising
Mandate

Vinge has advised SmartCella Holding AB in connection with fund raising

July 08, 2024 M&A

Vinge has advised SmartCella Holding AB in connection with its fund raising of EUR 50 million. The capital was invested by, among others, AstraZeneca, the Fourth Swedish National Pension Fund, AMF Pension, SEB-Stiftelsen, Handelsbanken Fonder and RoosGruppen AB. SmartCella is a world-leading biotechnology company pioneering the future of targeted therapies by combining first-in-class delivery platforms with cutting-edge cell and gene therapies.

Vinge’s team consisted of Jesper Ottergren, Sofie Bjärtun, Erik Sjöman, Stojan Arnerstål, Martin Madsen Svanberg, Annie Fällström, Joel Magnusson, Johan Severinsson and Nathalie Wikman.

Related

Vinge represents Cinven in connection with the acquisition of Ongoing Warehouse

 Vinge has represented the international private equity firm Cinven in connection with its acquisition of Ongoing Warehouse.
May 06, 2026

Vinge advises Fazer in connection with its acquisition of Aroma

 Fazer has entered into an agreement to acquire Konfektyrfabriken Aroma AB, a Swedish confectionery manufacturer known for its classic candy products such as Geléhallon, Hallonbåtar, Röda Hjärtan and Gräddkola. The acquisition strengthens Fazer's position in the Swedish confectionery market, particularly within pick & mix, packed candy, and seasonal products. The acquisition is subject to customary regulatory approvals.
May 06, 2026

Vinge represents Investor in connection with Electrolux Group’s rights issue

 Vinge represents Investor AB (publ) (“Investor”) in connection with Electrolux Group’s rights issue of approximately SEK 9 billion. Investor has undertaken to subscribe for Investor’s pro rata share, corresponding to approximately SEK 1.7 billion, and in addition to guarantee approximately SEK 1.7 billion.
May 06, 2026